WNT3 decreases GCP proliferation by inhibiting SHH dependent gene transcription. by Sandrine L. Anne (489755)

“…<p>(<i>A</i>) WNT3 decreased proliferation of GCPs by 40.3± 5.0% of the control (Con) (n=3) as measured by [³H]-Thymidine incorporation assay. …”

Image_1_IL-12p40/IL-23p40 Blockade With Ustekinumab Decreases the Synovial Inflammatory Infiltrate Through Modulation of Multiple Signaling Pathways Including MAPK-ERK and Wnt.TIF by Renée H. Fiechter (10230473)

“…We observed numerical decreases of all infiltrating cell subtypes at week 12, reaching statistical significance for CD68+ sublining macrophages. …”

%-change after 3 and 12 months of hormone therapy in trans women and trans men. by Moya H. Schutte (12245290)

Subjects:

Inflammation and hemostasis markers at 0, 3 and 12 months in trans men (absolute values). by Moya H. Schutte (12245290)

Subjects:

Decreased β-catenin levels in the retinas of the diabetic and OIR KO mice. by Kelu Kevin Zhou (637715)

Numbers of all fractures occurring in men, arranged in order of decreasing mean age, and with proportion of each of the fracture types in patients over 50, 65, and 75 years of age. by Camilla Bergh (9904522)

“…<p>Numbers of all fractures occurring in men, arranged in order of decreasing mean age, and with proportion of each of the fracture types in patients over 50, 65, and 75 years of age.…”

The expression of <i>Wnt1</i> gene was decreased in <i>Bmpr</i> double knockout mutants. by Lihua Qin (494786)

The TLR4 activator LPS decreases photoreceptor viability and reducesWnt-mediated protection from oxidative stress. by Hyun Yi (57741)

“…(C) Quantification of overlap indicates that Wnt3a reduced the number of caspase-positive photoreceptors and LPS decreased Wnt3a protection. …”

Increased expression of Fz5 receptor matched with a decrease in NeuN immunoreactivity at 16w. by Carlos González-Fernández (2794207)

Inflammation and hemostasis markers at 0, 3 and 12 months in trans women (absolute values). by Moya H. Schutte (12245290)

Subjects:

Hormone concentrations, body mass index and blood pressure at baseline and after 3 and 12 months of hormone therapy. by Moya H. Schutte (12245290)

Subjects:

UCHL1 depletion decreases Wnt signaling activity. by Patricia C. Sanchez-Diaz (403746)

“…Relative to control cells the Wnt signaling activity in the SJ-GBM2 knockdowns was decrease to 0.26 ± 0.05 (KD1) and 0.28 ± 0.09 (KD2) and, to 0.24 ± 0.04 (KD1) and 0.34 ± 0.13 (KD2) in the case of SF188 knockdowns. …”

The frequency of co-expression of ALDH and CGA progressively decreases during colon tumorigenesis in FAP patients. by Tao Zhang (43681)

“…Scale bars = 50 um.</p>…”

Wnt16 expression is decreased in femoral cortex of aged mice. by Henry Todd (811826)

Treatment with rSFRP4 results in decreased Wnt signalling. by Caroline E. Ford (289563)

“…(<b>E</b>) Relative expression of β-catenin dependent Wnt target genes was decreased in OVCAR3 cells treated with rSFRP4 (5 µg/ml) for 48 hours. qRT-PCR was performed in triplicate and normalised to three different housekeeping genes (SDHA, HSPCB, YWHZA) Expression of AXIN2, MYC and CCND1 were reduced in rSFP4 treated cells, in comparison with the control group. …”

Detailed meta–analyses in untreated hypothyroid patients compared with controls for each HRV parameters: RR intervals, SDNN, RMSSD, pNN50, TP, LF, HF, LF/HF. by Valentin Brusseau (12769704)

Baseline characteristics of the study population. by Moya H. Schutte (12245290)

Subjects:

Study flowchart. by Moya H. Schutte (12245290)

Subjects:

Minimal dataset. by Moya H. Schutte (12245290)

Subjects:

Activation of Wnt/β-catenin signaling decreases mRNA expressions of <i>Scx</i>, <i>Mkx</i> and <i>Tnmd</i> in rat TDCs. by Yasuzumi Kishimoto (4282138)

“…<p>Relative expressions of <i>Axin2</i>, <i>Scx</i>, <i>Mkx</i>, and <i>Tnmd</i> in TDCs treated with 50 ng/ml Wnt3a with or without 5 μM IWR (an inhibitor of β-catenin) <b>(A)</b>, 0 to 4 μM BIO (an activator of β-catenin) <b>(B)</b>, or 0 to 20 μM IWR <b>(C)</b> for 72 hrs. …”